AMH, Glucose Intolerance and Metabolic Syndrome in PCOS
NCT ID: NCT02676518
Last Updated: 2016-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2015-04-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
NCT03316469
Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
NCT01856894
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome
NCT06050265
Correlation of Insulin Resistance With Hormonal and Ovarian Morphological Characteristics in Patients With Polycystic Ovarian Syndrome
NCT05661565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test (OGTT).
* Metabolic syndrome is diagnosed by using the Harmonized criteria; the presence of any 3 of 5 following risk factors constitutes a diagnosis of metabolic syndrome.
1. Elevated waist circumference (\> 80 cm in Asian women)
2. Elevated triglycerides (\> 150 mg/dL)
3. Reduced HDL-cholesterol (\< 50 mg/dL)
4. Elevated blood pressure )systolic \> 130 and/or diastolic \> 85 mmHg)
5. Elevated fasting glucose ( \> 100 mg/dL)
* Percentage of glucose intolerance and metabolic syndrome in PCOS women as well was any differences in parameters between PCOS patients with and without glucose intolerance and metabolic syndrome will be analysed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
polycystic ovary syndrome women
PCOS women diagnosed by Rotterdam criteria visiting the Gynecologic Unit at King Chulalongkorn Memorial Hospital and meet the inclusion criteria and no exclusion criteria of the study
serum
Serum for serum anti-Mullerian hormone, 2-hour 75 gram oral glucose tolerance test and lipid profiles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
serum
Serum for serum anti-Mullerian hormone, 2-hour 75 gram oral glucose tolerance test and lipid profiles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous any hormonal uses in the last 3 months
* Previous hypoglycemic drugs or insulin-sensitising agents use in the last 3 months
* Previous chemotherapy, ovarian surgery, pelvic irradiation
* Menopause
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Porntip Sirayapiwat
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dhirapong Charoenvidya, MD
Role: STUDY_CHAIR
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University
Bangkok, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
057/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.